Cancer hazard identification: toward simplification and interpretability.
Boehringer-Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877-0368, USA.
R E
RE
Stoll
D000818:Animals; D015197:Carcinogenicity Tests / Q000639:trends*; D002273:Carcinogens / Q000633:toxicity*; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D009369:Neoplasms / Q000139:chemically induced* / Q000235:genetics; D018570:Risk Assessment
D002273:Carcinogens